With regard to the Public Health Agency of Canada, Health Canada, the National Advisory Committee on Immunization and COVID-19 vaccine deaths and injuries: (a) on what date did each government department first receive a report of a death from the (i) AstraZeneca, (ii) Pfizer, (iii) Moderna, COVID-19 vaccine; (b) what are the dates of the meetings in which the deaths from COVID-19 vaccines were discussed; (c) for each meeting in (b), what are the (i) names of those who attended the meeting, (ii) titles of those who attended the meeting, (iii) conclusions reached during the meeting; (iv) names of process documents modified after the meeting; (d) did the Public Health Agency of Canada or Health Canada develop a subcommittee to address deaths from the COVID-19 vaccines, and, if so, (i) who was on this committee, (ii) how often did it meet, (iii) what are the dates of the meetings, (iv) what were the outcomes of these meetings, (v) what are the names of the documents associated with these meetings; (e) did a government department notify any Member of Parliament or their staff about deaths from COVID-19 vaccines, and, if so, for each notification, (i) who was notified, (ii) how were they notified, (iii) on what date were they notified; (f) on what date did a government department first receive a report of a spontaneous abortion from a COVID-19 vaccine; (g) what are the dates of the meetings discussing the spontaneous abortions in (f); (h) for each meeting in (g), what are the (i) names of those who attended the meeting, (ii) titles of those who attended the meeting, (iii) conclusions reached during the meeting, (iv) names of process documents modified after the meeting; (i) did a government department notify any Member of Parliament or their staff about spontaneous abortions from COVID-19 vaccines, and, if so, for each notification, (i) who was notified, (ii) how were they notified, (iii) on what date were they notified; (j) on what date did a government department first receive a report of (i) a heart attack, (ii) a stroke, (iii) myocarditis, (iv) pericarditis from COVID-19 vaccines; (k) what are the dates of the meetings discussing the reports in (j); (l) for each meeting in (k) what are the (i) names of those who attended the meeting, (ii) titles of those who attended the meeting, (iii) conclusions reached during the meeting; (iv) names of process documents modified after the meeting; and (m) did a government department notify any Member of Parliament or their staff about heart attacks, strokes, myocarditis or pericarditis from COVID-19 vaccines, and if so, for each notification, (i) who was notified, (ii) how were they notified, (iii) on what date were they notified, (iv) what was the subject of the notification?
Q-1038 , 45th Parliament, 1st session May 26, 2025, to present
Question details
Asked by
Cathay Wagantall
(Yorkton—Melville)
Date asked
April 13, 2026
Answered
May 29, 2026
Response from
Department of Health
Topics
Response details
Responses details
Responses to written questions are provided by the relevant federal institutions. For accessibility issues or additional information, see the About page.
[]
{}